- Previous Rank61
- Revenue 3 Yr Annual Growth Rate27%
- Revenue 3 Yr Growth Rank57
- EPS 3 Yr Annual Growth Rate127%
- EPS 3 Yr Growth Rank9
- Total Return 3 Yr Annual Rate72%
- Total Return 3 Yr Rank4
More use of its top device, Impella 2.5, gives this producer of small heart pumps a healthy pulse. Its latest quarterly sales jumped 40% vs. the same period in 2015.
Company Information
Revenue and net income for the four quarters ended on or before April 30, 2016.!Total return for the period ended June 30, 2016.
Location | Danvers, Mass. |
Industry | Medical Products & Equipment |
Sector | Health Care |
Current Streak | 2 |
Years on List | 2 |
CEO | Michael Minogue |
Website | http://www.abiomed.com |
Revenue, Net Income
Revenue Past Four Quarters ($M) | $330 |
Net Income Past Four Quarters ($M) | $38 |
Growth Rates and Ranks
Revenue 3 Yr Growth Rank | 57 |
EPS 3 Yr Annual Growth Rate | 127% |
EPS 3 Yr Growth Rank | 9 |
Total Return 3 Yr Annual Rate | 72% |
Total Return 3 Yr Rank | 4 |